
Vanessa L. Ford
Supervisory Patent Examiner (ID: 6966, Phone: (571)272-0857 , Office: P/1646 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1646, 1674 |
| Total Applications | 502 |
| Issued Applications | 154 |
| Pending Applications | 66 |
| Abandoned Applications | 291 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5236058
[patent_doc_number] => 20070128215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Streptococcus phocae vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/580574
[patent_app_country] => US
[patent_app_date] => 2004-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4480
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128215.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580574
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580574 | Streptococcus phocae vaccine | Nov 30, 2004 | Abandoned |
Array
(
[id] => 7168487
[patent_doc_number] => 20050202042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Recombinant toxin A and toxin B protein carrier for polysaccharide conjugate vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/987508
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9997
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202042.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987508
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987508 | Recombinant toxin A and toxin B protein carrier for polysaccharide conjugate vaccines | Nov 11, 2004 | Abandoned |
Array
(
[id] => 6957956
[patent_doc_number] => 20050214326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Amino acid and zinc containing botulinum toxin pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 10/976528
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24720
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214326.pdf
[firstpage_image] =>[orig_patent_app_number] => 10976528
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/976528 | Amino acid and zinc containing botulinum toxin pharmaceutical compositions | Oct 28, 2004 | Abandoned |
Array
(
[id] => 6925408
[patent_doc_number] => 20050238663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Recombinant stabilizer botulinum toxin pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 10/976371
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24719
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238663.pdf
[firstpage_image] =>[orig_patent_app_number] => 10976371
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/976371 | Recombinant stabilizer botulinum toxin pharmaceutical compositions | Oct 28, 2004 | Abandoned |
Array
(
[id] => 252378
[patent_doc_number] => 07579010
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-25
[patent_title] => 'Botulinum toxin pharmaceutical compositions with a recombinant human serum albumin'
[patent_app_type] => utility
[patent_app_number] => 10/976672
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24723
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/579/07579010.pdf
[firstpage_image] =>[orig_patent_app_number] => 10976672
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/976672 | Botulinum toxin pharmaceutical compositions with a recombinant human serum albumin | Oct 28, 2004 | Issued |
Array
(
[id] => 4682236
[patent_doc_number] => 20080248462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Diagnostics and Therapeutics for Diseases Associated with Arginyl Aminopeptidase (Aminopeptidase B)-Like 1 (Rnpepl1)'
[patent_app_type] => utility
[patent_app_number] => 10/575364
[patent_app_country] => US
[patent_app_date] => 2004-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 34086
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248462.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575364 | Diagnostics and Therapeutics for Diseases Associated with Arginyl Aminopeptidase (Aminopeptidase B)-Like 1 (Rnpepl1) | Oct 11, 2004 | Abandoned |
Array
(
[id] => 7050302
[patent_doc_number] => 20050186189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Novel microorganism strain GM-020 of Lactobacillus rhamnosus and its use for treating obesity'
[patent_app_type] => utility
[patent_app_number] => 10/956138
[patent_app_country] => US
[patent_app_date] => 2004-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8268
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186189.pdf
[firstpage_image] =>[orig_patent_app_number] => 10956138
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/956138 | Novel microorganism strain GM-020 of Lactobacillus rhamnosus and its use for treating obesity | Oct 3, 2004 | Abandoned |
Array
(
[id] => 795472
[patent_doc_number] => 07429386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-30
[patent_title] => 'Stretch mark treatment'
[patent_app_type] => utility
[patent_app_number] => 10/934812
[patent_app_country] => US
[patent_app_date] => 2004-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12834
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/429/07429386.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934812
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934812 | Stretch mark treatment | Sep 2, 2004 | Issued |
Array
(
[id] => 7103437
[patent_doc_number] => 20050106163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen'
[patent_app_type] => utility
[patent_app_number] => 10/917211
[patent_app_country] => US
[patent_app_date] => 2004-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 23164
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106163.pdf
[firstpage_image] =>[orig_patent_app_number] => 10917211
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/917211 | Compositions and vaccines containing antigen(s) of Cryptosporidium parvum and of another pathogen | Aug 11, 2004 | Abandoned |
Array
(
[id] => 5193529
[patent_doc_number] => 20070082013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Use of botulinum toxin for producing drug for preventing or treating final phase of lung troubles'
[patent_app_type] => utility
[patent_app_number] => 10/564825
[patent_app_country] => US
[patent_app_date] => 2004-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1254
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10564825
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564825 | Use of botulinum toxin for producing drug for preventing or treating final phase of lung troubles | Jul 15, 2004 | Abandoned |
Array
(
[id] => 4504747
[patent_doc_number] => 07914801
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-03-29
[patent_title] => 'Metabolizable oil emulsion adjuvants and vaccines for enhancing immuno-properties of antibodies and their subpopulations'
[patent_app_type] => utility
[patent_app_number] => 10/887277
[patent_app_country] => US
[patent_app_date] => 2004-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 7265
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/914/07914801.pdf
[firstpage_image] =>[orig_patent_app_number] => 10887277
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/887277 | Metabolizable oil emulsion adjuvants and vaccines for enhancing immuno-properties of antibodies and their subpopulations | Jul 7, 2004 | Issued |
Array
(
[id] => 5084943
[patent_doc_number] => 20070274994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Virulence-Associated Adhesins'
[patent_app_type] => utility
[patent_app_number] => 10/562191
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 13087
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20070274994.pdf
[firstpage_image] =>[orig_patent_app_number] => 10562191
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/562191 | Virulence-Associated Adhesins | Jun 24, 2004 | Abandoned |
Array
(
[id] => 6971752
[patent_doc_number] => 20050037462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'GP75 as a tumor vaccine for melanoma'
[patent_app_type] => utility
[patent_app_number] => 10/877489
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9956
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037462.pdf
[firstpage_image] =>[orig_patent_app_number] => 10877489
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/877489 | GP75 as a tumor vaccine for melanoma | Jun 24, 2004 | Abandoned |
Array
(
[id] => 5693730
[patent_doc_number] => 20060153877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Remedies for dissease with hypermyotonia'
[patent_app_type] => utility
[patent_app_number] => 10/560789
[patent_app_country] => US
[patent_app_date] => 2004-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6227
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20060153877.pdf
[firstpage_image] =>[orig_patent_app_number] => 10560789
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/560789 | Remedies for dissease with hypermyotonia | Jun 17, 2004 | Abandoned |
Array
(
[id] => 492221
[patent_doc_number] => 07211265
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-01
[patent_title] => 'Vaccination modalities'
[patent_app_type] => utility
[patent_app_number] => 10/841476
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3424
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/211/07211265.pdf
[firstpage_image] =>[orig_patent_app_number] => 10841476
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/841476 | Vaccination modalities | May 9, 2004 | Issued |
Array
(
[id] => 7329835
[patent_doc_number] => 20040254127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Method for determining predisposition to a venous thromboembolic disease'
[patent_app_type] => new
[patent_app_number] => 10/830094
[patent_app_country] => US
[patent_app_date] => 2004-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3537
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254127.pdf
[firstpage_image] =>[orig_patent_app_number] => 10830094
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/830094 | Method for determining predisposition to a venous thromboembolic disease | Apr 22, 2004 | Abandoned |
Array
(
[id] => 809637
[patent_doc_number] => 07416734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-26
[patent_title] => 'Vaccines for Mycoplasma bovis and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/825391
[patent_app_country] => US
[patent_app_date] => 2004-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6699
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/416/07416734.pdf
[firstpage_image] =>[orig_patent_app_number] => 10825391
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/825391 | Vaccines for Mycoplasma bovis and methods of use | Apr 13, 2004 | Issued |
Array
(
[id] => 809637
[patent_doc_number] => 07416734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-26
[patent_title] => 'Vaccines for Mycoplasma bovis and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/825391
[patent_app_country] => US
[patent_app_date] => 2004-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6699
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/416/07416734.pdf
[firstpage_image] =>[orig_patent_app_number] => 10825391
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/825391 | Vaccines for Mycoplasma bovis and methods of use | Apr 13, 2004 | Issued |
Array
(
[id] => 6957955
[patent_doc_number] => 20050214325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Compositions and methods to increase the effect of a neurotoxin treatment'
[patent_app_type] => utility
[patent_app_number] => 10/810391
[patent_app_country] => US
[patent_app_date] => 2004-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9405
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214325.pdf
[firstpage_image] =>[orig_patent_app_number] => 10810391
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/810391 | Compositions and methods to increase the effect of a neurotoxin treatment | Mar 25, 2004 | Abandoned |
Array
(
[id] => 7436223
[patent_doc_number] => 20040185063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-23
[patent_title] => 'Broken cell wall chlorella and process for preparation thereof'
[patent_app_type] => new
[patent_app_number] => 10/802766
[patent_app_country] => US
[patent_app_date] => 2004-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7185
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20040185063.pdf
[firstpage_image] =>[orig_patent_app_number] => 10802766
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/802766 | Broken cell wall chlorella and process for preparation thereof | Mar 17, 2004 | Abandoned |